| abstract |
Disclosed are compositions derived from non-primate mammals having reduced expression of alpha 1, 3 gal and their use in food products, food additives, cosmetic products, cosmetic additives, medical products, medical devices and products used in research and production of therapeutics. The compositions and methods disclosed are particularly useful to subjects diagnosed with α-Gal Syndrome (AGS). |